|Study Name||Study Title||Status||Recruit.||Contact|
Phase I-II study of low dose CdA combined with valproic acid (VPA) in previously treated B-cell chronic lymphocytic ...
An open-label, multicenter, expanded access study of INC424 (ruxolitinib) for patients with primary myelofibrosis (P...
Phase 3, randomized, open-label study of the efficacy and safety of CRIZOTINIB versus pemetrexed/cisplatin or pemetrexed/carboplatin iN previousl...
12-week multi-center, randomized, double-blind, parallel-group study to assess the efficacy, safety and tolerability...
A randomized, double-blind, placebo-controlled phase III study to evaluate the efficacy and safety of pazopanib as a...
This page provides the list of clinical studies currently registered in the LuxCLIN platform in the different therapeutic areas. By clicking on each study title, more information is displayed concerning the study objective and the participation conditions.